secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-11-25T23:59:59+00:00
Accession:  0001193125-25-297177
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.03, 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical files for Chapter 11 bankruptcy; Nasdaq delisting effective Dec 1
--------------------------------------------------------------------------------

- Filed voluntary Chapter 11 petition on Nov 23, 2025 in Delaware (Case No. 25-12109).
- Nasdaq delisting notice received; trading suspended Dec 1, moving to OTC under symbol CLSDQ.
- Company intends to sell substantially all assets through a Section 363 auction.
- First-day motions filed to continue normal operations during the bankruptcy process.
- Assets include SCS Microinjector platform, CLS-AX program, and multiple licensing deals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/0001193125-25-297177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/d41251d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-297177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer